The Fifth Circuit Court of Appeals has ruled in favor of several tobacco companies, affirming that the Food and Drug Administration (FDA) exceeded its authority in requiring additional warning labels on cigarette packaging. The case, R J Reynolds Tobacco Company v. FDA (Docket No. 25-40137), centers on the FDA’s attempt to enforce eleven warning statements instead of the nine mandated by Congress in the Family Smoking Prevention and Tobacco Control Act (TCA). This ruling is significant as it clarifies the limits of the FDA's regulatory power over tobacco products.
The plaintiffs in this case include R J Reynolds Tobacco Company, Santa Fe Natural Tobacco Company, ITG Brands LLC, and several others. They challenged the FDA's new rule that required cigarette manufacturers to display eleven warning labels, arguing that the agency had no authority to increase the number of required warnings beyond the nine specified by Congress. The Fifth Circuit's decision comes after a lower court had already granted the plaintiffs an injunction against the FDA's rule, finding a substantial likelihood of success on their claim.
The dispute began when the FDA issued a final rule in 2022 that required cigarette packaging and advertisements to feature eleven graphic warning statements, which included images depicting the health risks associated with smoking. This rule was a departure from the TCA, which clearly outlined nine specific warnings that must be displayed. The FDA’s action was met with immediate legal challenges from the tobacco companies, leading to the current appeal.
The Fifth Circuit's ruling upheld the lower court's decision, stating, "the statutory text points one way: the FDA may require the nine warnings Congress prescribed—no more." This ruling was made by Circuit Judges Southwick, Willett, and Ho, with Judge Willett writing the opinion. The court emphasized that Congress had provided a detailed framework for the required warnings and that the FDA's authority to adjust these warnings was limited and conditional.
The court further explained that the TCA explicitly states that it is unlawful for cigarette packages to fail to bear one of the specified nine labels. The judges noted that the FDA's attempt to impose additional warnings was not supported by the statutory language, which clearly delineates the number of required warnings. The ruling reiterated that the FDA’s authority to adjust the warnings was restricted to visual adjustments, such as type size and format, and did not extend to adding new warnings.
This ruling has significant implications for the tobacco industry and regulatory agencies. It reinforces the principle that federal agencies must operate within the bounds of authority granted to them by Congress. The decision may also impact future regulatory actions by the FDA and other agencies, as it underscores the importance of adhering to statutory language when creating rules and regulations.
The Fifth Circuit's decision not only affirms the lower court's ruling but also sets a precedent regarding the limits of agency authority. This ruling could discourage the FDA from attempting to impose additional requirements that are not explicitly authorized by Congress, particularly in the context of public health regulations.
Looking ahead, the FDA may choose to appeal this ruling to the Supreme Court, although details on any potential appeal were not available in the court filing. Additionally, a related case is pending in the Eleventh Circuit, where another court has vacated the same rule based on procedural grounds, further complicating the regulatory landscape for tobacco products.